News + Filings Transactions
|
Reardon Tighe
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/03/2023 | Janux Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 110k | $14.02 | $1.5M | | 01/03/2023 |
| 01/03/2022 | Janux Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 116.8k | $20.24 | $2.4M | | 01/03/2022 |
| 06/15/2021 | Janux Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 900.3k | $0.00 | $0 | See footnote | 06/15/2021 |
| 06/15/2021 | Janux Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 2.1M | $0.00 | $0 | See footnote | 06/15/2021 |
| 06/15/2021 | Janux Therapeutics, Inc. | | Purchase | Common Stock | 629.4k | $17.00 | $10.7M | See footnote | 06/15/2021 |
| 06/15/2021 | Janux Therapeutics, Inc. | | Conversion | Common Stock | 1.2M | $0.00 | $0 | See footnote | 06/15/2021 |
| 06/15/2021 | Janux Therapeutics, Inc. | | Conversion | Common Stock | 2.7M | $0.00 | $0 | See footnote | 06/15/2021 |
| 01/23/2020 | Synthorx, Inc. | THOR | Disposition | Employee Stock Option (right to buy) | 30k | $11.00 | $330k | | 01/23/2020 |
| 01/23/2020 | Synthorx, Inc. | THOR | Disposition | Employee Stock Option (right to buy) | 18.7k | $4.64 | $86.9k | | 01/23/2020 |
| 01/23/2020 | Synthorx, Inc. | THOR | Other | Common Stock | 1.7M | $68.00 | $114.4M | By Avalon X SPV I, L.P. | 01/23/2020 |
| 01/23/2020 | Synthorx, Inc. | THOR | Other | Common Stock | 43.7k | $68.00 | $3M | | 01/23/2020 |
| 12/11/2018 | Synthorx, Inc. | THOR | Conversion | Common Stock | 1.1M | $0.00 | $0 | By Avalon X SPV I, L.P. | 12/11/2018 |
| 12/11/2018 | Synthorx, Inc. | THOR | Purchase | Common Stock | 545.5k | $11.00 | $6M | By Avalon X SPV I, L.P. | 12/11/2018 |
| 12/11/2018 | Synthorx, Inc. | THOR | Conversion | Series C Preferred Stock | 1.8M | $0.00 | $0 | By Avalon X SPV I, L.P. | 12/11/2018 |
| 12/06/2018 | Synthorx, Inc. | THOR | Grant | Employee Stock Option (right to buy) | 30k | $11.00 | $330k | | 12/06/2018 |
|